Literature DB >> 30959386

Low eicosapentaenoic acid and gamma-linolenic acid levels in breast adipose tissue are associated with inflammatory breast cancer.

Marie Chas1, Caroline Goupille2, Flavie Arbion3, Philippe Bougnoux4, Michelle Pinault2, Marie Lise Jourdan2, Stephan Chevalier2, Lobna Ouldamer5.   

Abstract

OBJECTIVE: Since it is thought that breast adipose tissue could influence breast cancer clinical presentation, we wanted to characterize specifically the relationship between breast adipose tissue fatty acid profile and Inflammatory Breast cancer (IBC).
METHODS: Two hundred thirty-four women presenting with breast cancer were managed in our centre between January 2009 and December 2011. Breast adipose tissue specimens were collected during breast surgery. We established the biochemical profile of adipose tissue fatty acids (FA) by gas chromatography and assessed whether there were differences in function of the presence of breast inflammation or not.
RESULTS: We found that IBC was associated with decreased levels in breast adipose tissue of eicosapentaenoic acid (EPA), one of the two main polyunsaturated n-3 fatty acids (n-3 PUFA) of marine origin, but also with decreased levels of Gamma Linolenic acid (GLA). Inversely, an increase in palmitic acid levels was associated with IBC.
CONCLUSION: These differences in lipid content may contribute to the occurrence of breast cancer inflammation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adipose samples; Breast cancer; Eicosapentaenoic acid; Inflammation

Mesh:

Substances:

Year:  2019        PMID: 30959386     DOI: 10.1016/j.breast.2019.04.001

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  7 in total

1.  Accumulation of Arachidonic Acid, Precursor of Pro-Inflammatory Eicosanoids, in Adipose Tissue of Obese Women: Association with Breast Cancer Aggressiveness Indicators.

Authors:  Lobna Ouldamer; Marie-Lise Jourdan; Michelle Pinault; Flavie Arbion; Caroline Goupille
Journal:  Biomedicines       Date:  2022-04-26

Review 2.  Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease.

Authors:  Delphine Fontaine; Sandy Figiel; Romain Félix; Sana Kouba; Gaëlle Fromont; Karine Mahéo; Marie Potier-Cartereau; Aurélie Chantôme; Christophe Vandier
Journal:  J Lipid Res       Date:  2020-04-07       Impact factor: 5.922

3.  Effects of Steady Low-Intensity Exercise on High-Fat Diet Stimulated Breast Cancer Progression Via the Alteration of Macrophage Polarization.

Authors:  Min Kyoon Kim; Yesl Kim; SeungHwa Park; Eunju Kim; Yerin Kim; Yuri Kim; Jung-Hyun Kim
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

4.  Low Levels of Omega-3 Long-Chain Polyunsaturated Fatty Acids Are Associated with Bone Metastasis Formation in Premenopausal Women with Breast Cancer: A Retrospective Study.

Authors:  Caroline Goupille; Philippe G Frank; Flavie Arbion; Marie-Lise Jourdan; Cyrille Guimaraes; Michelle Pinault; Gilles Body; Stephan Chevalier; Philippe Bougnoux; Lobna Ouldamer
Journal:  Nutrients       Date:  2020-12-15       Impact factor: 5.717

5.  Metabolomic profiling identifies biomarkers and metabolic impacts of surgery for colorectal cancer.

Authors:  Feng Zhuang; Xuesong Bai; Yang Shi; Le Chang; Wanchao Ai; Juan Du; Wei Liu; Humin Liu; Xukun Zhou; Zhong Wang; Tao Hong
Journal:  Front Surg       Date:  2022-08-25

6.  The Effect of Diet Supplementation with Pomegranate and Bitter Melon on Lipidomic Profile of Serum and Cancerous Tissues of Rats with Mammary Tumours.

Authors:  Agnieszka Białek; Małgorzata Jelińska; Małgorzata Białek; Tomasz Lepionka; Małgorzata Czerwonka; Marian Czauderna
Journal:  Antioxidants (Basel)       Date:  2020-03-17

7.  LINC00894 Enhances the Progression of Breast Cancer by Sponging miR-429 to Regulate ZEB1 Expression.

Authors:  De-Feng Meng; Hua Shao; Chuan-Bo Feng
Journal:  Onco Targets Ther       Date:  2021-05-25       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.